Food consumption, cytochrome P450 3A4 (CYP3A4) presystemic inhibitors, and bioavailability of saquinavir.
Amariles
P
P
D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D001682:Biological Availability; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004359:Drug Therapy, Combination; D004435:Eating; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics*; D006801:Humans; D011899:Ranitidine / Q000008:administration & dosage; D019258:Saquinavir / Q000493:pharmacokinetics*
D000897:Anti-Ulcer Agents; D017320:HIV Protease Inhibitors; D011899:Ranitidine; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D019258:Saquinavir